|
Jeil Pharmaceutical Company Limited - Company Profile Snapshot
| Company Profile: |
Jeil Pharmaceutical Company Limited |
| Ticker: |
002620 |
| Exchanges: |
SEO |
| 2008 Sales: |
319,440,000,000 |
| Major Industry: |
Drugs, Cosmetics & Health Care |
| Sub Industry: |
Ethical Drug Manufacturers |
| Country: |
KOREA (SOUTH) |
| Employees: |
783 |
Business Description
Jeil Pharmaceutical Company Limited. The Company's principal activities are manufacturing and selling pharmaceutical products. Its products include duodenum ulcer treatments, antibiotics, antihypertensive agents, polyuria remedies, sepsis treatments, hypochondria treatments, antiphlogistics and treatments for ulcer caused by chronic arterial block. Other activity includes distributing hyperlipoidemia treatments, neuromuscular disorder treatments and anesthetics, as well as imported medicines such as gastrointestinal agents and anticancer medicines for head and neck cancer, rectal cancer and colon cancer.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
